Anheuser-Busch InBev stock (NYSE: BUD) recently reported its Q3 results, with revenues falling short but earnings exceeding the street estimates. The company reported revenue of $15.05 billion and an adjusted profit of $0.98 per share, compared to the consensus estimates of $15.57 billion and $0.89, respectively. Despite an earnings beat, BUD stock declined around 8% post the results announcement, as the company saw a surprising dip in volume.
Anheuser-Busch InBev’s revenues of $15.05 billion in Q3 reflected a 2.1% y-o-y growth. Looking at segments, North America revenue was up 1.5%, Middle Americas up 1.9%, South America up 5.6%, EMEA gained 8.2%, while Asia Pacific was down 9.5%. The overall volume declined by 2.4%, led by Asia Pacific, down 9.5%. The decline in volume was surprising, given the consensus estimates were for marginal growth. The company attributed this decline to soft consumer demand in China and Argentina. Anheuser-Busch InBev saw its EBITDA margin improve 110 bps to 36.0% in Q3. The bottom line of $0.98 reflected a 14% y-o-y growth.
Looking at BUD stock, the decline in volume didn’t sit well with the investors, evident from an 8% drop post results announcement. We estimate Anheuser-Busch InBev’s valuation to be $68 per share, reflecting around 15% upside from its current levels of $59. Our forecast is based on a 20x P/E multiple for BUD and expected earnings of $3.32 on a per-share and adjusted basis for the full year 2024. The 20x figure aligns with the stock average P/E ratio over the last three years. However, if the volume decline were to continue over the coming quarters, it may warrant a decline in valuation multiple for BUD.
BUD stock, down 9% this year, has underperformed the broader markets, with the S&P 500 index rising 20%. Looking at a slightly longer period, the change in BUD stock over the recent years has been far from consistent, although annual returns were considerably less volatile than the S&P 500. Returns for BUD stock were -13% in 2021, -1% in 2022, and 8% in 2023. Notably, the Trefis High Quality Portfolio, with a collection of 30 stocks, is less volatile. And it has outperformed the S&P 500 each year over the same period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.
While BUD stock looks like it can see higher levels, it is helpful to see how Anheuser-Busch InBev peers fare on metrics that matter. You will find other valuable comparisons for companies across industries at Peer Comparisons.
Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates